<DOC>
	<DOCNO>NCT02332954</DOCNO>
	<brief_summary>The purpose study describe association/correlation change patient-reported cognitive symptom work productivity gainfully employ patient receive vortioxetine Major Depressive Episode ( MDE ) .</brief_summary>
	<brief_title>Assessment Work Productivity Relationship With Cognitive Symptoms Patients With MDD Taking Vortioxetine</brief_title>
	<detailed_description>This interventional , Canadian , multi-site , open-label , single cohort , flexible-dose study . The study emulate naturalistic real-life setting . Investigators include Primary Care Physicians Psychiatrists work outpatient clinic . The study include adult patient diagnose MDD accord DSM-5™ . Approximately 200 patient enrol study . There approximately 100 patient receive vortioxetine first treatment current MDE 100 patient switched vortioxetine due inadequate response current antidepressant medication treatment . All patient treat vortioxetine per product monograph , dos determine appropriate investigator . The total study duration Baseline end follow-up approximately 56 week .</detailed_description>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Neurobehavioral Manifestations</mesh_term>
	<mesh_term>Vortioxetine</mesh_term>
	<criteria>The patient man woman , age ≥18 year &lt; 65 year ( In province British Columbia , patient must age 19 year old order give Informed Consent ) The patient engage volunteer work gainful employment ( work ≥20 hour per week ) enrol fulltime postsecondary study vocational training . The patient outpatient consult Primary Care Physician Psychiatrist . Patients must diagnosis MDD accord Diagnostic Statistical Manual Mental Disorders , 5th Edition ( DSM5™ ) classification code 296.3x . The current MDE confirm investigator . The report duration current MDE least 3 month . The patient Baseline score ≥15 QIDSSR . The patient report least minimal level cognitive symptom define Baseline score ≥30 PDQD20 . The patient capable communicate site personnel able conduct digitsymbol substitution test ( DSST ) . The patient score &gt; 69 DSST Screening/Baseline . The patient , opinion investigator , able complete study assessment include , limited , patientreported assessment DSST . The patient current diagnosis history manic hypomanic episode , schizophrenia psychotic disorder , include major depression psychotic feature . The current depressive symptom consider investigator resistant 2 adequate antidepressant treatment least 6 week duration maximum recommend dose ( accord Canadian labeling ) . Other protocol define inclusion exclusion criterion apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Depression</keyword>
	<keyword>Major Depressive Disorder</keyword>
	<keyword>Cognition</keyword>
	<keyword>Cognitive symptom</keyword>
	<keyword>vortioxetine</keyword>
	<keyword>real life</keyword>
	<keyword>naturalistic</keyword>
</DOC>